Eli Lilly (LLY) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to -$133.1 million.
- Eli Lilly's Non Operating Income fell 31467.74% to -$133.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$572.8 million, marking a year-over-year decrease of 468240.0%. This contributed to the annual value of -$218.6 million for FY2024, which is 32606.0% down from last year.
- Eli Lilly's Non Operating Income amounted to -$133.1 million in Q3 2025, which was down 31467.74% from -$90.6 million recorded in Q2 2025.
- Over the past 5 years, Eli Lilly's Non Operating Income peaked at $321.1 million during Q1 2021, and registered a low of -$635.9 million during Q3 2021.
- Its 5-year average for Non Operating Income is -$58.3 million, with a median of -$77.3 million in 2021.
- Per our database at Business Quant, Eli Lilly's Non Operating Income skyrocketed by 43635.19% in 2022 and then tumbled by 98191.88% in 2025.
- Quarter analysis of 5 years shows Eli Lilly's Non Operating Income stood at -$77.3 million in 2021, then skyrocketed by 436.35% to $260.0 million in 2022, then crashed by 53.46% to $121.0 million in 2023, then plummeted by 190.99% to -$110.1 million in 2024, then decreased by 20.89% to -$133.1 million in 2025.
- Its last three reported values are -$133.1 million in Q3 2025, -$90.6 million for Q2 2025, and -$239.0 million during Q1 2025.